Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Um, Jae Young ^a   Rim, Hong Kun ^a   Kim, Su Jin ^b   Kim, Hye Lin ^a   Hong, Seung Heon ^c  

^a Kyung Hee University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOSINE; GENOMIC DNA; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; THYMINE; TRIACYLGLYCEROL; PRIMER DNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; IL1 ALPHA GENE; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PROADIPOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ANIMALS; BASE SEQUENCE; BODY MASS INDEX; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1ALPHA; MALE; MICE; MICE, INBRED C57BL; OBESITY; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84455161618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029524     Document Type: Article

References (43)

1. Miranda PJ, Defronzo RA, Califf RM, Guyton JR, (2005) Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 149 (1): 33-45.
2. Wellen KE, Hotamisligil GS, (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (12): 1785-1788.
3. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, et al. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147 (11): 5340-5351.
4. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, et al. (1999) Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 (16): 2221-2222.
5. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, et al. (2004) Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004 110 (12): 1564-1571.
6. He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, et al. (2006) Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol Endocrinol 20 (1): 114-124.
7. Dinarello CA, (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16 (5-6): 457-499.
8. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr, (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160 (2): 618-623.
9. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA, (1986) Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 78 (6): 1432-1438.
10. Dinarello CA, Wolff SM, (1993) The role of interleukin-1 in disease. N Engl J Med 328 (2): 106-113.
11. Di Renzo L, Bigioni M, Del Gobbo V, Premrov MG, Barbini U, et al. (2007) Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res 55 (2): 131-138.
12. Raymond NC, Dysken M, Bettin K, Eckert ED, Crow SJ, et al. (2000) Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord 28 (3): 293-302.
13. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, et al. (2004) Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 (25): 3842-3848.
14. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52 (3): 812-817.
15. Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, et al. (1992) Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 4 (2): 83-89.
16. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, et al. (2002) Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin 1-α. Immunogenetics 54 (2): 82-86.
17. Kawaguchi Y, Tochimoto A, Hara M, Kawamoto M, Sugiura T, et al. (2007) Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 59 (6): 441-448.
18. Sweeting HN, (2007) Measurement and definitions of obesity in childhood and adolescence: a field guide for the uninitiated. Nutr J 6: 32.
19. Um JY, Chung HS, Song MY, Shin HD, Kim HM, (2004) Association of interleukin-1beta gene polymorphism with body mass index in women. Clin Chem 50 (3): 647-650.
20. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, et al. (2000) An IL 6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 96 (7): 2562-2567.
21. Tai H, Endo M, Shimada Y, Gou E, Orima K, et al. (2002) Association of interleukin-1 receptor antagonist gene polymorphisms with early onset periodontitis in Japanese. J Clin Periodontol 29 (10): 882-888.
22. Folch J, Lees M, Sloane Stanly GH, (1957) A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1): 497-509.
23. Prieur AM, Kaufmann MT, Griscelli C, Dayer JM, (1987) Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 2 (8570): 1240-1242.
24. Du Clos TW, (2000) Function of C-reactive protein. Ann Med 32 (4): 274-278.
25. Yap SH, Moshage HJ, Hazenberg BP, Roelofs HM, Bijzet J, et al. (1991) Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta 1091 (3): 405-408.
26. Misra A, (2004) C-reactive protein in young individuals: problems and implications for Asian Indians. Nutrition 20 (5): 478-481.
27. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC, (1996) C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (7038): 1061-1065.
28. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW, (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 (4): 972-978.
29. Ouchi N, Walsh K, (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380 (1-2): 24-30.
30. Wei X, Chen X, Fontanilla C, Zhao L, Liang Z, et al. (2007) C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line. Life Sci 80 (12): 1152-1156.
31. McDowell TL, Symons JA, Ploski R, Førre O, Duff GW, (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 38 (2): 221-228.
32. Rainero I, Bo M, Ferrero M, Valfrè W, Vaula G, et al. (2004) Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging 25 (10): 1293-1298.
33. Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, et al. (2003) Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 24 (7): 927-931.
34. Moreira PR, Costa JE, Gomez RS, Gollob KJ, Dutra WO, (2007) The IL1A (-889) gene polymorphism is associated with chronic periodontal disease in a sample of Brazilian individuals. J Periodontal Res 42 (1): 23-30.
35. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC, et al. (1997) Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 82 (9): 3084-3086.
36. Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, et al. (2003) Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52 (5): 1104-1110.
37. Mrácek T, Cannon B, Houstek J, (2004) IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes. Cytokine 26 (1): 9-15.
38. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, et al. (2006) Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49 (9): 2162-2173.
39. Uno T, He J, Usui I, Kanatani Y, Bukhari A, et al. (2008) Long-term interleukin-1alpha treatment inhibits insulin signaling via IL-6 production and SOCS3 expression in 3T3-L1 adipocytes. Horm Metab Res 40 (1): 8-12.
40. Kamari Y, Werman-Venkert R, Shaish A, Werman A, Harari A, et al. (2007) Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 195 (1): 31-38.
41. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, et al. (1996) Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157 (1): 291-296.
42. Wilasrusmee C, Da Silva M, Singh B, Kittur S, Siddiqui J, et al. (2002) A new in vitro model to study endothelial injury. J Surg Res 104 (2): 131-136.
43. Braddock M, Quinn A, (2004) Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3 (4): 330-339.